This archive contains the following articles listed by volume, issue and page number:

Volume 20, 2016 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2016 Pg. 4	PreScription: Starting Year 20! Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
Jan/Feb 2016 Pg. 13-18	Microbial Identification in Pharmaceutical Compounding Author(s): Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
Jan/Feb 2016 Pg. 20-27	Basic Principles of Lyophilization, Part 2 Author(s): Akers Michael J
Jan/Feb 2016 Pg. 29-36	Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Author(s): Pritchett Jon, Mixon William, O'Connell Kevin
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Jan/Feb 2016 Pg. 46	Calculations Author(s): Stockton Shelly J
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 49	Aripiprazole 10-mg Oral Dissolving Tablets Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 50	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 52	Mupirocin Calcium 2% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 53	Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 54	Thrombin 1,000 Units/mL Topical Solution, Sterile Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 55	Tropicamide 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 56	Vancomycin 5% and Amikacin 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 57	Voriconazole 10-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 58-62	Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Author(s): Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
Jan/Feb 2016 Pg. 63-70	Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation Author(s): Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R
Jan/Feb 2016 Pg. 71-80	A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Author(s): Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
Jan/Feb 2016 Pg. 81-85	Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Jan/Feb 2016 Pg. 86-87	PostScription: The Home Field Advantage Author(s): Cabaleiro Joe
Mar/Apr 2016 Pg. 92	PreScription: Compounding: A Changing Paradigm Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 95-96	Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Author(s): McCrory Gary
Mar/Apr 2016 Pg. 99-104	Root Cause Analysis, Part 2: Sterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Mar/Apr 2016 Pg. 114-122	Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives Author(s): Palmeira-de-Oliveira Rita, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo
Mar/Apr 2016 Pg. 125-134	Basics of Compounding: Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 137-141	Formulation and Stability of Solutions Author(s): Akers Michael J
Mar/Apr 2016 Pg. 142	Calculations Author(s): Stockton Shelly J
Mar/Apr 2016 Pg. 144	Blue Goo Anti-Itch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 145	Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 146	Medicated Polyox Bandage for Skin Ulcers Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 148-154	Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Mar/Apr 2016 Pg. 155-158	Utilization of Compounded Medications in an Oral Medicine Practice Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016 Pg. 159-163	Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Author(s): Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 2016 Pg. 164-166	Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Author(s): Nahata Milap C
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
May/Jun 2016 Pg. 180	PreScription: Patient Access to Pharmaceuticals Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 182-186	Current Perspectives on the Syringe Delivery System Author(s): Akers Michael J
May/Jun 2016 Pg. 189-192	Compounding in Nigeria Author(s): Alfred-Ugbenbo Deghinmotei, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick
May/Jun 2016 Pg. 194	IACP Names Voliva Executive Vice President Author(s): McCrory Gary
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 217-222	Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Author(s): Akers Michael J
May/Jun 2016 Pg. 224	Calculations Author(s): Stockton Shelly J
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 227	Cefotetan Disodium Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 229	Dexpanthenol 5% Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 230	Indomethacin Gel Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 232	Montelukast Sodium 5-mg Fast-Dissolving Film Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 233	Pain-Away II Headache Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 234	Sodium Nitroprusside 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 235	Zolpidem Tartrate 5-mg and 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 236-238	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Author(s): Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
May/Jun 2016 Pg. 239-246	Topical Metered-dosing Dispenser Performance Evaluation Author(s): Liu Qiang, Kupiec Thomas C, Vu Nicole T
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016 Pg. 262-263	PostScription: Supporting Your Alma Mater: Whose World Will You Change? Author(s): Tigelaar Michele
Jul/Aug 2016 Pg. 268 View Sample	PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing? Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Jul/Aug 2016 Pg. 277-280	Case Report: Pediatric Scar Management After Open-heart Surgery Author(s): Phan Ha, Harger Beau, Estrada Nick
Jul/Aug 2016 Pg. 283-292	Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Author(s): Noorian Shaun, Vahedi Navid
Jul/Aug 2016 Pg. 294-296	IACP's 2016 Compounders on Capitol Hill Asks Author(s):
Jul/Aug 2016 Pg. 298-305	Basics of Compounding: Compounding Films Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 307-314	Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Author(s): Akers Michael J
Jul/Aug 2016 Pg. 316-317	Calculations Author(s): Stockton Shelly J
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 320	Mebendazole 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 321	Neomycin Sulfate 25-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 322	Nystatin 100,000-units Vaginal Inserts Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 323	1,2-Octanediol 5% Topical Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 324	Phytonadione 1-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 325	Plasmingen and Hyaluronate Sodium Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 327	Tretinoin 10-mg Oral Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 328-332	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016 Pg. 333-337	Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Author(s): Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Jul/Aug 2016 Pg. 338-342	Stability of Ampicillin in Normal Saline and Buffered Normal Saline Author(s): Maher Moureddine, Jensen Kara J, Lee David, Nix David E
Jul/Aug 2016 Pg. 343-346	Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Author(s): Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
Jul/Aug 2016 Pg. 347-350	Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 356	PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Sep/Oct 2016 Pg. 377-378	More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Author(s): Voliva John
Sep/Oct 2016 Pg. 381-386	Quality Control Analytical Methods: Method Validation Author(s): Klang Mark G, Williams LaVonn A
Sep/Oct 2016 Pg. 389-396	Basics of Compounding: Clinical Pharmaceutics, Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 405	Calculations Author(s): Stockton Shelly J
Sep/Oct 2016 Pg. 406	Clobazam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 407	Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 409	Levetiracetam 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 410	Naproxen 5% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 411	Permethrin 1% Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 412	Progesterone 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 413	Sodium Phosphate Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 414	Tetracaine Hydrochloride 2% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 415	Tromethamine Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 416-420	Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 2016 Pg. 421-425	Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Author(s): Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
Sep/Oct 2016 Pg. 426-434	Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Sep/Oct 2016 Pg. 435-437	Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Author(s): Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
Sep/Oct 2016 Pg. 438-439	A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Author(s): Tannous Elias, Tal Yana, Amarny Kamal
Nov/Dec 2016 Pg. 444	PreScription: Two Decades of IJPC Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Nov/Dec 2016 Pg. 457-458	U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Author(s):
Nov/Dec 2016 Pg. 461-467	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Author(s): Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016 Pg. 469-474	Why Become Pharmacy Compounding Accreditation Board Accredited? Author(s): Dillon L Rad
Nov/Dec 2016 Pg. 477-479	The "Lists": What Do They Mean? Author(s): Voliva John
Nov/Dec 2016 Pg. 481-484	Introduction to Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 502	Calculations Author(s): Stockton Shelly J
Nov/Dec 2016 Pg. 504	Alendronate 70-mg/75-mL Drinkable Formulation Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 505	Bosentan 6.25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 506	Capsaicin 0.025% and Doxepin 3.3% Cream Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 507	Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 508	Erlotinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 510	Imatinib 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 511	Lapatinib Ditosylate 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 512	Melatonin 2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 513	Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 514-516	Stability of Fentanyl Citrate in Polyolefin Bags Author(s): Donnelly Ronald F
Nov/Dec 2016 Pg. 517-520	Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016 Pg. 521-525	Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Author(s): Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Nov/Dec 2016 Pg. 526-527	PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Author(s): Rost Erika